Keyphrases
Interleukin-33 (IL-33)
100%
Eosinophils
100%
Pulmonary Arterial
100%
Interleukin-5 Receptor
100%
Antibody-dependent Cellular Cytotoxicity
100%
Anti-interleukin 5
100%
Arterial Hypertrophy
100%
Interleukin
60%
Chimeric Antibody
40%
Therapeutic Target
20%
Allergy
20%
Asthma
20%
Clinical Application
20%
Monoclonal Antibody
20%
Lung
20%
Interleukin-5 (IL-5)
20%
Pulmonary Hypertension
20%
Anti-interleukin-1
20%
Asthma Symptoms
20%
Human Trials
20%
Fc Region
20%
Human IgG1
20%
Chimeric Monoclonal Antibody
20%
Eosinophil Count
20%
Fab Region
20%
Immunology and Microbiology
Eosinophil Granulocyte
100%
Interleukin 33
100%
Interleukin 5 Receptor Alpha Subunit
100%
Immunology
100%
Antibody-Dependent Cell-Mediated Cytotoxicity
83%
Cytokine
66%
Interleukin
66%
Monoclonal Antibody
33%
Interleukin 5
33%
Interleukin-5 Receptor
33%
Chimeric Antibody
33%
Asthma
16%
Eosinophil Count
16%
Immunoglobulin G1
16%
Receptor Antibody
16%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 33
100%
Elimination
100%
Interleukin 5 Receptor Alpha
100%
Antibody-Dependent Cell-Mediated Cytotoxicity
100%
Cytokine
80%
Monoclonal Antibody
40%
Interleukin 5
40%
Interleukin 5 Receptor
40%
Chimeric Antibody
40%
Asthma
20%
Clinical Trial
20%
Pulmonary Hypertension
20%
Immunoglobulin G1
20%
Receptor Antibody
20%